StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
52
This year
3
Publishing Date
2024 - 02 - 09
1
2024 - 02 - 08
1
2024 - 01 - 11
1
2023 - 12 - 15
1
2023 - 12 - 13
1
2023 - 11 - 30
1
2023 - 11 - 25
1
2023 - 11 - 08
1
2023 - 10 - 25
1
2023 - 10 - 24
1
2023 - 06 - 30
1
2023 - 06 - 26
1
2023 - 06 - 16
1
2023 - 06 - 02
2
2023 - 01 - 24
1
2022 - 12 - 09
1
2022 - 12 - 08
1
2022 - 11 - 18
1
2022 - 11 - 16
1
2022 - 11 - 04
1
2022 - 10 - 13
1
2022 - 10 - 12
1
2022 - 09 - 26
1
2022 - 08 - 31
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 07 - 27
1
2022 - 06 - 29
1
2022 - 06 - 25
1
2022 - 06 - 17
1
2022 - 05 - 23
1
2022 - 04 - 14
1
2022 - 03 - 29
1
2022 - 03 - 15
1
2022 - 02 - 28
1
2022 - 02 - 18
1
2022 - 02 - 10
1
2022 - 01 - 05
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 12 - 09
1
2021 - 12 - 08
1
2021 - 11 - 23
1
2021 - 11 - 22
2
2021 - 11 - 19
1
2021 - 11 - 09
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 12
1
2021 - 04 - 19
1
Sector
Commercial services
33
Communications
52
Construction
1
Consumer durables
19
Consumer non-durables
61
Consumer services
9
Distribution services
9
Educational services
1
Electronic technology
26
Energy minerals
3
Finance
80
Finance and insurance
11
Health care and social assistance
3
Health services
23
Health technology
4532
Industrial services
2
Information
4
Manufacturing
210
Mining, quarrying, and oil and gas extraction
3
Miscellaneous
2
N/a
196
Non-energy minerals
4
Process industries
28
Producer manufacturing
16
Professional, scientific, and technical services
30
Retail trade
12
Technology services
67
Transportation
2
Transportation and warehousing
2
Utilities
1
Tags
Agreement
1
Als
1
Antibiotics
1
Antibody
1
Application
2
Authorization
10
Award
1
Awards
3
Candidate
3
Children
8
Collaboration
1
Comirnaty
1
Comirnaty®
1
Companies
2
Conference
1
Control
1
Covid
6
Covid-19
18
Deal
1
Designation
1
Disease
1
Drug
1
Earnings
1
Emergency use authorization
7
Europe
1
Fast track designation
1
Fda
11
Financial
1
Financial results
1
Funding
1
Granted
1
Health
1
Influenza
1
Innovation
1
Market
4
Medical-device
1
Merge
5
N/a
46
Order
5
Pharm-country
3
Phase 3
1
Pipeline
1
Positive
1
Reach
4
Report
3
Research
7
Response
4
Results
4
Revenue
1
Sanofi
1
Study
2
Teva
2
Tiona
1
Transdermal
1
Treatment
1
Trial
3
Usa
1
Vaccine
24
Year
2
Entities
Abbott laboratories
1
Astrazeneca plc
2
Biontech se
26
Bristol-myers squibb company
1
Edgewell personal care
1
Elanco animal health incorporated
1
Eli lilly and company
2
Ericsson
1
General motors company
1
Glaxosmithkline plc
3
Immunogen, inc.
2
Johnson & johnson
2
Kb home
1
Kellogg company
2
Kt corporation
1
London stock exchange group
1
Merck & company, inc.
1
Novartis ag
5
Novo nordisk a/s
1
Nutriband inc.
1
Omeros corporation
1
Orange
49
Pfizer, inc.
26
Proximus
1
Rani therapeutics holdings inc class a
1
Reckitt benckiser group plc
1
Sanofi
52
Seagen inc.
1
Sorrento therapeutics, inc.
2
Teladoc health, inc.
1
Teva pharmaceutical industries limited
2
Teva pharmaceutical industries ltd
2
Veon ltd.
1
Viatris inc.
2
Zoetis inc.
1
Symbols
AAPL
89
ALHC
63
ARVL
110
ATEX
58
AWRE
183
BMO
96
BTGOF
76
CIXX
87
CSCO
116
ERIC
360
FNCTF
7171
GOGO
102
GOOG
100
GOOGL
100
HON
72
IDT
102
INTC
94
IRDM
208
KDDIF
59
KDDIY
59
KLR
64
KT
126
LMNR
296
LUMN
248
MS
90
MSFT
91
NIPNF
97
NOK
70
NOKBF
104
ORCL
73
PHI
79
PHTCF
77
PTNR
64
RCI
181
RCIAF
123
RY
94
SAP
79
SAPGF
72
SCS
137
SFBQF
63
SFTBF
63
SFTBY
63
SHEN
88
SPI
68
T
433
TAC
100
TDS
143
TEF
68
TIGO
164
TIXT
178
TRI
88
TRP
64
TU
353
USM
95
VEON
227
VG
76
VOD
157
VZ
1211
WOW
85
ZTCOF
102
Exchanges
Nasdaq
52
Nyse
39
Crawled Date
2024 - 02 - 09
1
2024 - 02 - 08
1
2024 - 01 - 11
1
2023 - 12 - 15
1
2023 - 12 - 13
1
2023 - 11 - 30
1
2023 - 11 - 25
1
2023 - 11 - 08
1
2023 - 10 - 25
1
2023 - 10 - 24
1
2023 - 06 - 30
1
2023 - 06 - 26
1
2023 - 06 - 16
1
2023 - 06 - 02
2
2023 - 01 - 24
1
2022 - 12 - 09
1
2022 - 12 - 08
1
2022 - 11 - 18
1
2022 - 11 - 17
1
2022 - 11 - 04
1
2022 - 10 - 13
1
2022 - 10 - 12
1
2022 - 09 - 26
1
2022 - 08 - 31
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 07 - 27
1
2022 - 06 - 29
1
2022 - 06 - 25
1
2022 - 06 - 17
1
2022 - 05 - 23
1
2022 - 04 - 14
1
2022 - 03 - 29
1
2022 - 03 - 15
1
2022 - 02 - 28
1
2022 - 02 - 18
1
2022 - 02 - 10
1
2022 - 01 - 05
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 12 - 09
1
2021 - 12 - 08
1
2021 - 11 - 23
1
2021 - 11 - 22
2
2021 - 11 - 19
1
2021 - 11 - 09
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 12
1
2021 - 04 - 19
1
Crawled Time
00:00
1
01:00
1
02:00
1
07:00
4
08:20
1
11:00
9
12:00
5
13:00
2
13:30
1
14:00
4
14:20
1
14:30
1
15:00
2
15:20
1
15:30
1
16:00
2
16:20
1
17:00
2
18:00
4
20:00
1
21:00
2
22:00
2
23:00
3
Source
nutriband.com
1
www.biospace.com
6
www.capgemini.com
1
www.globenewswire.com
28
www.interpublic.com
2
www.prnewswire.com
14
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Communications
symbols :
Sny
save search
PRODUCT OF THE YEAR USA NAMES 2024 AWARD WINNERS
Published:
2024-02-09
(Crawled : 14:00)
- prnewswire.com
K
|
$56.07
1.01%
0.0%
1.8M
|
Consumer Non-Durables
|
1.04%
|
O:
-0.38%
H:
0.03%
C:
-2.27%
EPC
4
|
$35.32
-0.4%
0.0%
250K
|
Consumer Non-Durables
|
-10.16%
|
O:
-0.35%
H:
0.61%
C:
0.31%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.48%
|
O:
1.11%
H:
0.0%
C:
0.0%
award
year
usa
Publicis Groupe : Full Year 2023 Results
Published:
2024-02-08
(Crawled : 07:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-5.11%
|
O:
-2.28%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.67%
|
O:
-1.64%
H:
0.0%
C:
0.0%
K
|
$56.07
1.01%
0.0%
1.8M
|
Consumer Non-Durables
|
3.39%
|
O:
3.37%
H:
1.93%
C:
-1.01%
KBH
S
|
$60.92
-1.47%
0.0%
890K
|
Consumer Durables
|
3.1%
|
O:
0.25%
H:
1.03%
C:
0.9%
GM
|
News
|
$42.46
-0.47%
0.02%
11M
|
Consumer Durables
|
10.18%
|
O:
0.31%
H:
0.26%
C:
-0.49%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.71%
|
O:
-2.25%
H:
0.0%
C:
0.0%
year
results
Sanofi Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
Published:
2024-01-11
(Crawled : 02:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-11.51%
|
O:
1.1%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.75%
|
O:
0.69%
H:
0.0%
C:
0.0%
report
innovation
sanofi
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published:
2023-12-15
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
2.12%
|
O:
-3.0%
H:
2.15%
C:
2.15%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
25.97%
|
O:
-0.48%
H:
0.0%
C:
-0.44%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-6.12%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
25.78%
|
O:
-4.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.03%
|
O:
-0.93%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.89%
|
O:
-2.23%
H:
0.28%
C:
-0.11%
reach
research
market
Sodexo announces the composition of Pluxee’s future Board of Directors
Published:
2023-12-13
(Crawled : 07:00)
- globenewswire.com
LDNXF
|
$112.038
-12.32%
1K
|
Finance
|
-2.95%
|
O:
2.99%
H:
0.0%
C:
-2.02%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.75%
|
O:
-0.06%
H:
2.36%
C:
2.36%
BGAOY
|
News
|
$1.5
38.89%
1.1K
|
Information
|
-18.01%
|
O:
1.56%
H:
0.0%
C:
0.0%
LNSTY
|
$28.87
0.53%
82K
|
Finance and Insurance
|
-2.23%
|
O:
-0.61%
H:
2.21%
C:
1.81%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.25%
|
O:
-0.27%
H:
2.28%
C:
2.16%
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.04%
|
O:
-0.35%
H:
0.0%
C:
0.0%
TEVA
|
$13.18
0.69%
0.46%
6.6M
|
Health Technology
|
35.09%
|
O:
-0.52%
H:
3.73%
C:
1.87%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.57%
|
O:
-1.09%
H:
0.0%
C:
0.0%
disease
treatment
collaboration
teva
deal
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published:
2023-11-25
(Crawled : 08:20)
- prnewswire.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
ELAN
|
$13.41
-1.69%
-0.45%
4.1M
|
Process Industries
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
ZTS
|
News
|
$151.94
-0.71%
2.38%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
vaccine
reach
research
market
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published:
2023-11-08
(Crawled : 14:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
1.24%
|
O:
-0.33%
H:
0.0%
C:
0.0%
TEVA
|
$13.18
0.69%
0.46%
6.6M
|
Health Technology
|
44.8%
|
O:
2.54%
H:
3.23%
C:
-1.29%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
1.78%
|
O:
1.62%
H:
0.0%
C:
0.0%
revenue
teva
financial
results
Oral Antibiotics Market to Reach $28.8 Billion, Globally, by 2032 at 2.5% CAGR: Allied Market Research
Published:
2023-10-25
(Crawled : 14:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-11.0%
|
O:
0.4%
H:
1.29%
C:
1.29%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
22.06%
|
O:
-0.44%
H:
0.33%
C:
-1.1%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-2.2%
|
O:
0.64%
H:
0.46%
C:
-0.09%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.45%
|
O:
1.43%
H:
0.64%
C:
-0.09%
reach
antibiotics
research
market
Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published:
2023-10-24
(Crawled : 01:00)
- prnewswire.com
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
24.66%
|
O:
0.45%
H:
2.46%
C:
1.67%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-1.97%
|
O:
-0.17%
H:
1.02%
C:
0.4%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.77%
|
O:
0.77%
H:
0.0%
C:
0.0%
reach
research
market
Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published:
2023-06-30
(Crawled : 18:00)
- prnewswire.com
SRNE
|
$0.0275
-8.85%
53K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
drug
companies
antibody
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published:
2023-06-26
(Crawled : 21:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
64.93%
|
O:
2.15%
H:
1.18%
C:
0.43%
SRNE
|
$0.0275
-8.85%
53K
|
Health Technology
|
-92.12%
|
O:
-1.0%
H:
4.2%
C:
1.3%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
16.38%
|
O:
0.82%
H:
0.02%
C:
-0.85%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.23%
|
O:
0.17%
H:
0.0%
C:
0.0%
OMER
|
$3.32
-3.21%
-3.31%
270K
|
Health Technology
|
-36.48%
|
O:
0.19%
H:
2.22%
C:
1.76%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
65.12%
|
O:
0.58%
H:
2.57%
C:
0.26%
companies
pipeline
trial
Extended Release Injectable Drugs Research Report 2023: Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape
Published:
2023-06-16
(Crawled : 23:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
report
control
research
IPG Named Most Effective Holding Company at the U.S. Effie Awards
Published:
2023-06-02
(Crawled : 22:00)
- interpublic.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
awards
IPG Receives Back-to-Back Title as Most Effective Holding Company at the Effie Awards
Published:
2023-06-02
(Crawled : 20:00)
- interpublic.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
awards
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published:
2023-01-24
(Crawled : 11:00)
- nutriband.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-6.48%
|
O:
-0.27%
H:
0.1%
C:
0.1%
NTRB
|
$4.01
2.74%
8.9K
|
Manufacturing
|
14.25%
|
O:
-2.85%
H:
0.0%
C:
-1.76%
RANI
|
$7.77
13.1%
11.58%
1.4M
|
|
8.02%
|
O:
-1.1%
H:
1.91%
C:
-3.82%
MRK
|
$125.37
0.25%
0.1%
6.1M
|
Health Technology
|
13.82%
|
O:
0.11%
H:
0.0%
C:
-1.35%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
12.98%
|
O:
-1.02%
H:
0.0%
C:
-0.86%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-6.1%
|
O:
-0.72%
H:
0.0%
C:
0.0%
conference
transdermal
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published:
2022-12-09
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-3.09%
|
O:
-0.89%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-50.39%
|
O:
-0.06%
H:
2.11%
C:
-0.06%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.05%
|
O:
-0.15%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-49.75%
|
O:
-0.05%
H:
0.75%
C:
-0.83%
covid-19
fda
designation
candidate
vaccine
influenza
fast track designation
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published:
2022-12-08
(Crawled : 16:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
12.43%
|
O:
-0.76%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.45%
|
O:
0.5%
H:
0.16%
C:
0.16%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-48.87%
|
O:
-0.12%
H:
3.36%
C:
3.19%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.34%
|
O:
-1.32%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-46.91%
|
O:
0.37%
H:
5.31%
C:
5.26%
covid-19
fda
children
vaccine
authorization
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages
Published:
2022-11-18
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
7.35%
|
O:
1.56%
H:
0.52%
C:
0.52%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-46.84%
|
O:
0.64%
H:
0.39%
C:
-0.84%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
6.01%
|
O:
2.2%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-48.07%
|
O:
-0.29%
H:
0.78%
C:
0.37%
report
response
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published:
2022-11-16
(Crawled : 00:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
6.04%
|
O:
-1.22%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-46.53%
|
O:
-0.52%
H:
1.45%
C:
1.11%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
3.59%
|
O:
-2.28%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-47.64%
|
O:
-1.45%
H:
2.36%
C:
2.31%
covid-19
candidate
vaccine
study
← Previous
1
2
3
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.